Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART
- 20 June 2006
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 78 (8) , 1003-1010
- https://doi.org/10.1002/jmv.20655
Abstract
HIV-1 p24 antigen (p24) measurement by signal amplification-boosted ELISA of heat-denatured plasma is being evaluated as an alternative to HIV-1 RNA quantitation in resource-poor settings. Some observations suggested that virion-associated p24 is suboptimally detected using Triton X-100-based virus dissociation buffer (kit buffer). A new reagent (SNCR buffer) containing both denaturing and non-denaturing detergents was therefore developed and evaluated. The SNCR buffer increased the measured p24 concentration about 1.5- to 3-fold in HIV-negative plasma reconstituted with purified HIV-1 particles, while not increasing the background. Among 127 samples of HIV-1-positive patients with moderate to high concentrations of HIV-1 RNA the increase was about threefold across the entire concentration range (P < 0.0001). Specificity before neutralization among prospectively tested clinical samples ruled HIV-negative was 828 of 845 (98.0%) for the SNCR buffer and 464 of 479 (96.9%) for kit buffer. Specificity after confirmatory neutralization of reactive samples or a follow-up test was 100% with either buffer. Surprisingly, the SNCR buffer revealed a p24 reactivity in 115 of 187 samples (61.5%) from adult patients exhibiting undetectable HIV-1 RNA below 5 copies/ml for a duration of 6–30 months under HAART (3.7% with kit buffer). The rate of p24 reactivity in these patients did not decrease with duration of HAART. In conclusion, the SNCR buffer improves the detection of particle-associated HIV-1 p24, thereby increasing the measured p24 concentration in samples with medium to high HIV-1 RNA. It also uncovers the presence of a p24 reactivity, whose identity remains to be determined, in a significant fraction of samples with undetectable HIV-1 RNA under long-term HAART. J. Med. Virol. 78:1003–1010, 2006.Keywords
This publication has 33 references indexed in Scilit:
- Evaluation of Two Commercially Available, Inexpensive Alternative Assays Used for Assessing Viral Load in a Cohort of Human Immunodeficiency Virus Type 1 Subtype C-Infected Patients from South AfricaJournal of Clinical Microbiology, 2005
- Lowering the Detection Limits of HIV-1 Viral Load Using Real-Time Immuno-PCR for HIV-1 p24 AntigenAmerican Journal of Clinical Pathology, 2004
- Lack of Longitudinal Intrapatient Correlation between p24 Antigenemia and Levels of Human Immunodeficiency Virus (HIV) Type 1 RNA in Patients with Chronic HIV Infection during Structured Treatment InterruptionsJournal of Clinical Microbiology, 2004
- Heat‐Denatured Human Immunodeficiency Virus Type 1 Protein 24 Antigen: Prognostic Value in Adults with Early‐Stage DiseaseThe Journal of Infectious Diseases, 2002
- Identification and Characterization of Two Closely Related Unclassifiable Endogenous Retroviruses in Pythons (Python molurusandPython curtus)Journal of Virology, 2002
- Comparison of an Assay Using Signal Amplification of the Heat-Dissociated p24 Antigen with the Roche Monitor Human Immunodeficiency Virus RNA AssayJournal of Clinical Microbiology, 2002
- Human Immunodeficiency Virus Type 1 p24 Concentration Measured by Boosted ELISA of Heat‐Denatured Plasma Correlates with Decline in CD4 Cells, Progression to AIDS, and Survival: Comparison with Viral RNA MeasurementThe Journal of Infectious Diseases, 2000
- Prospective Evaluation of Amplification‐Boosted ELISA for Heat‐Denatured p24 Antigen for Diagnosis and Monitoring of Pediatric Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 1999
- Variability and Prognostic Values of Virologic and CD4 Cell Measures in Human Immunodeficiency Virus Type 1‐Infected Patients with 200–500 CD4 Cells/mm3(ACTG 175)The Journal of Infectious Diseases, 1998
- Virologic and Serologic Markers of Rapid Progression to AIDS After HIV-1 SeroconversionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996